Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 06:02 am Sale | 2026-06-30 | 13G | CONTINEUM THERAPEUTICS INC CL CTNM | BALYASNY ASSET MANAGEMENT L.P. | 2,335,550 7.140% | -82,173![]() (-3.40%) | Filing History |
| 2026-08-14 06:02 am Purchase | 2026-06-30 | 13G | CELLECTAR BIOSCIENCES INC CLRB | BALYASNY ASSET MANAGEMENT L.P. | 798,382 9.990% | 798,382![]() (New Position) | Filing History |
| 2026-08-14 06:01 am Purchase | 2026-06-30 | 13G | CRESCENT BIOPHARMA, INC CBIO | BALYASNY ASSET MANAGEMENT L.P. | 1,662,917 6.030% | 152,884![]() (+10.12%) | Filing History |
| 2026-08-14 06:00 am Sale | 2026-06-30 | 13G | CAMP4 THERAPEUTICS CORP COM CAMP | BALYASNY ASSET MANAGEMENT L.P. | 2,591,097 4.990% | -41,340![]() (-1.57%) | Filing History |
| 2026-05-15 06:41 am Purchase | 2026-03-31 | 13G | CONTINEUM THERAPEUTICS INC CL CTNM | BALYASNY ASSET MANAGEMENT L.P. | 2,417,723 7.400% | 104,923![]() (+4.54%) | Filing History |
| 2026-05-15 06:39 am Purchase | 2026-03-31 | 13G | ENHABIT INC EHAB | BALYASNY ASSET MANAGEMENT L.P. | 2,645,992 5.220% | 2,645,992![]() (New Position) | Filing History |
| 2026-05-15 06:38 am Unchanged | 2026-03-31 | 13G | OPUS GENETICS, INC. IRD | BALYASNY ASSET MANAGEMENT L.P. | 5,110,373 7.180% | 0 (Unchanged) | Filing History |
| 2026-05-15 06:36 am Sale | 2026-03-31 | 13G | TXNM ENERGY, INC. TXNM | BALYASNY ASSET MANAGEMENT L.P. | 1,237,500 6.970% | -5,896,043![]() (-82.65%) | Filing History |
| 2026-05-15 06:33 am Purchase | 2026-03-31 | 13G | REZOLUTE INC RZLT | BALYASNY ASSET MANAGEMENT L.P. | 5,048,421 5.280% | 5,048,421![]() (New Position) | Filing History |
| 2026-05-15 06:31 am Purchase | 2026-03-31 | 13G | OVID THERAPEUTICS INC OVID | BALYASNY ASSET MANAGEMENT L.P. | 7,029,223 5.330% | 7,029,223![]() (New Position) | Filing History |
| 2026-05-15 06:31 am Purchase | 2026-03-31 | 13G | CRESCENT BIOPHARMA, INC CBIO | BALYASNY ASSET MANAGEMENT L.P. | 1,510,033 5.480% | 1,510,033![]() (New Position) | Filing History |
| 2026-05-15 06:29 am Purchase | 2026-03-31 | 13G | CAMP4 THERAPEUTICS CORP COM CAMP | BALYASNY ASSET MANAGEMENT L.P. | 2,632,437 5.070% | 2,632,437![]() (New Position) | Filing History |
| 2026-05-15 06:28 am Purchase | 2026-03-31 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | BALYASNY ASSET MANAGEMENT L.P. | 5,089,939 9.990% | 5,089,939![]() (New Position) | Filing History |
| 2026-05-15 06:23 am Sale | 2026-03-31 | 13G | LEXEO THERAPEUTICS INC LXEO | BALYASNY ASSET MANAGEMENT L.P. | 7,176,144 9.690% | -45,411![]() (-0.63%) | Filing History |
| 2026-05-15 06:18 am Purchase | 2026-03-31 | 13G | TALKSPACE INC TALK | BALYASNY ASSET MANAGEMENT L.P. | 8,866,727 5.310% | 8,866,727![]() (New Position) | Filing History |
| 2026-05-15 06:17 am Unchanged | 2026-03-31 | 13G | BEYOND AIR INC XAIR | BALYASNY ASSET MANAGEMENT L.P. | 38,163 7.250% | 0 (Unchanged) | Filing History |
| 2026-05-15 06:13 am Sale | 2026-03-31 | 13G | VERASTEM INC VSTM | BALYASNY ASSET MANAGEMENT L.P. | 1,360,391 1.550% | -3,406,763![]() (-71.46%) | Filing History |
| 2026-05-15 06:12 am Purchase | 2026-03-31 | 13G | RALLYBIO CORP COM RLYB | BALYASNY ASSET MANAGEMENT L.P. | 376,573 7.120% | 376,573![]() (New Position) | Filing History |
| 2026-05-15 06:12 am Purchase | 2026-03-31 | 13G | NASUS PHARMA LTD NSRX | BALYASNY ASSET MANAGEMENT L.P. | 1,169,910 9.990% | 1,169,910![]() (New Position) | Filing History |
| 2026-05-15 06:07 am Sale | 2026-03-31 | 13G | MINERVA NEUROSCIENCES INC NERV | BALYASNY ASSET MANAGEMENT L.P. | 4,323,112 9.990% | -7,203![]() (-0.17%) | Filing History |

